Back to Search Start Over

Inhibition by Marine Algae of Chikungunya Virus Isolated From Patients in a Recent Disease Outbreak in Rio de Janeiro.

Authors :
Cirne-Santos CC
Barros CS
Nogueira CCR
Azevedo RC
Yamamoto KA
Meira GLS
de Vasconcelos ZFM
Ratcliffe NA
Teixeira VL
Schmidt-Chanasit J
Ferreira DF
Paixão ICNP
Source :
Frontiers in microbiology [Front Microbiol] 2019 Oct 24; Vol. 10, pp. 2426. Date of Electronic Publication: 2019 Oct 24 (Print Publication: 2019).
Publication Year :
2019

Abstract

Chikungunya virus (CHIKV) infection is one of the most challenging re-emergent diseases caused by a virus, and with no specific antiviral treatment it has now become a major public health concern. In this investigation, 25 blood samples were collected from patients with characteristic CHIKV symptoms and submitted to a virus isolation protocol, which detected 3 CHIKV isolates. These samples were evaluated by sequencing for the characterization of the strains and any homology to viruses circulating in Brazil during a recent outbreak. These viruses were used for the development of antiviral assays. Subsequently, the inhibitory effects of seaweed extracts on CHIKV replication were studied. The marine species of algae tested were Bryothamnion triquetrum, Caulerpa racemosa, Laurencia dendroidea, Osmundaria obtusiloba , Ulva fasciata , and Kappaphycus alvarezii , all of which are found in different countries including Brazil. The results revealed high levels of CHIKV inhibition, including extracts of O. obtusiloba with inhibition values of 1.25 μg/mL and a selectivity index of 420. Viral inhibition was dependent on the time of addition of extract of O. obtusiloba to the infected cells, with the optimal inhibition occurring up to 16 h after infection. Neuron evaluations with O. obtusiloba were performed and demonstrated low toxicity, and in infected neurons we observed high inhibitory activity in a dose-dependent manner. These results indicate that the algal extracts may be promising novel candidates for the development of therapeutic agents against CHIKV infections.<br /> (Copyright © 2019 Cirne-Santos, Barros, Nogueira, Azevedo, Yamamoto, Meira, Vasconcelos, Ratcliffe, Teixeira, Schmidt-Chanasit, Ferreira and Paixão.)

Details

Language :
English
ISSN :
1664-302X
Volume :
10
Database :
MEDLINE
Journal :
Frontiers in microbiology
Publication Type :
Academic Journal
Accession number :
31708898
Full Text :
https://doi.org/10.3389/fmicb.2019.02426